12 Results for "

PDK1-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "PDK1-IN-1" in MCE Product Catalog:

Cat. No.: HY-W070306
CAS No.: 1207836-10-9
PDK1-IN-1 (Compound 2-11) is a PDK1 inhibitor. PDK1-IN-1 is also useful as inhibitor of other kinases such as FGFR3, NTRK3, RP-S6K and WEE1. PDK1-IN-1 selectively inhibits microtubule affinity regulating kinase (MARK). PDK1-IN-1 can be used for researches of myeloproliferative disorders, cancer and Alzheimer's disease .
loading...
    loading...
7
7 Publications Verification
Cat. No.: HY-11005
CAS No.: 702674-56-4
Purity:  99.13%
Target:  

PDK-1 Apoptosis

Research Areas:  

Cancer

BX-912 is a direct, selective, and ATP-competitive PDK1 inhibitor (IC50=26 nM). BX-912 blocks PDK1/Akt signaling in tumor cells and inhibits the anchorage-dependent growth of a variety of tumor cell lines in culture or induces apoptosis .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-N0047
CAS No.: 50773-41-6
Polyphyllin I is a bioactive constituent extracted from Paris polyphylla, has strong anti-tumor activity. Polyphyllin I is an activator of the JNK signaling pathway and is an inhibitor of PDK1/Akt/mTOR signaling. Polyphyllin I induces autophagy, G2/M phase arrest and apoptosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-124379
CAS No.: 402-71-1
Purity:  98.05%
Synonyms: L-1-Tosylamido-2-phenylethyl chloromethyl ketone; L-TPCK
TPCK (L-1-Tosylamido-2-phenylethyl chloromethyl ketone; L-TPCK) is an effective serine protease inhibitor and also a blocker of the PDK1/Akt pathway. TPCK can modify the E7 protein in actively keratinocyte cells. TPCK can induce cellular apoptosis, suppress tumor growth, reduce hypoxic-ischemic brain injury in rat pups, and affect vascular permeability in inflamed rats .
loading...
    loading...
Cat. No.: HY-W998345
Target:  

PROTACs PDK-1 Akt

Research Areas:  

Cancer

SMART1 is a highly specific and CRBN-dependent PROTAC that can effectively degrade Smurf1. SMART1 can block the PDK1-Akt signaling pathway in KRAS mutant colorectal cancer. SMART1 can inhibit tumor growth in KRAS mutant colorectal cancer (CRC) xenograft models .
loading...
    loading...
Cat. No.: HY-117809
CAS No.: 1643958-85-3
Purity:  98.90%
Target:  

PDK-1

Research Areas:  

Cancer

PDK1-IN-2 is a small molecule inhibitor of 3-phosphoinositol-dependent protein kinase-1 (PDK1). PDK1-IN-2 inhibits the binding of PDK1 to its substrate by competitively binding to the PIF pocket of PDK1, thereby inhibiting the kinase activity and downstream signaling of PDK1. PDK1-IN-2 can be used for cell survival and proliferation in cancer .
loading...
    loading...
Cat. No.: HY-149275
CAS No.: 3041957-90-5
Research Areas:  

Cancer

PKM2/PDK1-IN-1, one of shikonin thioether derivatives, is a dual inhibitor of PKM2/PDK1. PKM2/PDK1-IN-1 inhibits the proliferation of NSCLC cells, and induces apoptosis. PKM2/PDK1-IN-1 induces intercellular ROS production, and regulates the apoptotic proteins, to involves in mitochondrial and death receptor pathway .
loading...
    loading...
Cat. No.: HY-129426
CAS No.: 331253-86-2
Target:  

Akt

Research Areas:  

Cancer

PDK1/Akt/Flt dual pathway inhibitor is one of a component of KP372-1 (HY-15673 ), and inhibits PDK1/Akt/Flt dual pathway .
loading...
    loading...
Cat. No.: HY-124288
CAS No.: 1919884-11-9
Target:  

Drug Derivative

Research Areas:  

Others

PDK1/AurA-IN-1 is an active compound.
loading...
    loading...
Cat. No.: HY-N0047R
CAS No.: 50773-41-6
Polyphyllin I (Standard) is the analytical standard of Polyphyllin I. This product is intended for research and analytical applications. Polyphyllin I is a bioactive constituent extracted from Paris polyphylla, has strong anti-tumor activity. Polyphyllin I is an activator of the JNK signaling pathway and is an inhibitor of PDK1/Akt/mTOR signaling. Polyphyllin I induces autophagy, G2/M phase arrest and apoptosis .
loading...
    loading...
Cat. No.: HY-11005R
CAS No.: 702674-56-4
Research Areas:  

Cancer

BX-912 (Standard) is the analytical standard of BX-912 (HY-11005). This product is intended for research and analytical applications. BX-912 is a direct, selective, and ATP-competitive PDK1 inhibitor (IC50=26 nM). BX-912 blocks PDK1/Akt signaling in tumor cells and inhibits the anchorage-dependent growth of a variety of tumor cell lines in culture or induces apoptosis .
loading...
    loading...
Cat. No.: HY-N2942
CAS No.: 52328-96-8
Bisdemethoxycurcumin is an orally effective curcuminoid. Bisdemethoxycurcumin downregulates pro-inflammatory cytokines in macrophages by inhibiting the phosphorylation of PI3K/Akt and p38 MAPK. Bisdemethoxycurcumin relieves autophagy inhibition and promotes lipophagy to clear vascular smooth muscle foam cells by inhibiting the PDK1/Akt/mTOR pathway. Bisdemethoxycurcumin activates the cAMP/Epac/AMPKα axis and the NRF2/HO-1 antioxidant axis, thereby indirectly inhibiting the phosphorylation of NF-κB p65 and pro-inflammatory outputs such as IL-1β/IL-6/TNF-α, so as to alleviate pulmonary oxidative stress, inflammatory infiltration and pulmonary edema. Bisdemethoxycurcumin blocks NLRP3-mediated pyroptosis and protects cartilage extracellular matrix degradation by activating NRF2/HO-1. Bisdemethoxycurcumin also exerts a synergistic effect with potassium iodide against Candida .
loading...
    loading...
  • 1